4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-21-007458
EVP R&D, Chief Medical Officer gave up 5,086 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 16,970 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-02-20 | Option exercise | +10,095 | 27,131 | D: show line 1 in the form | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-02-20 | Shares withheld for taxes | −3,064 | $19.58 | $59,993 | 24,067 | D: show line 2 in the form |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-02-21 | Option exercise | +6,875 | 30,942 | D: show line 3 in the form | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-02-21 | Shares withheld for taxes | −2,022 | $19.58 | $39,591 | 28,920 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-02-20 | Option exercise · Restricted Stock Unit Award | −10,095 | 30,287 | D: show line 5 in the form | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2021-02-21 | Option exercise · Restricted Stock Unit Award | −6,875 | 13,750 | D: show line 6 in the form |
Loading xslF345X03/form4.xml…